Boston Scientific Corporation / Endo International plc (American Medical Systems Men's Health and Prostate Health)
2015 · Asset Purchase · $1.6B · Complete
Announcement Sentiment
93
Strongly positive
Boston Scientific acquired Endo's AMS Men's Health and Prostate Health businesses for $1.6B upfront plus up to $50M based on 2016 sales, advancing Endo's transition to specialty pharma. Closed August 4, 2015.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Accretive
Pipeline outcome
Assets Advanced
Assessment window: 5yr post-close.
Key facts
AnnouncedMar 02, 2015
ClosedAug 04, 2015
Deal value$1.6B
Deal typeAsset Purchase
Therapeutic areaBenign prostatic hyperplasia, male stress urinary incontinence, erectile dysfunction
IndicationsBenign prostatic hyperplasia, male stress urinary incontinence, erectile dysfunction
Key assetsAMS urology portfolio (BPH, male SUI, ED devices)